Skip to main content
Top
Published in:

29-08-2023 | Opioids

A Cost Model for a Low-Threshold Clinic Treating Opioid Use Disorder

Authors: Sarah E. Wakeman, MD, Elizabeth Powell, MPH, Syed Shehab, MD, Grace Herman, MS, Laura Kehoe, MD, MPH, Robert S. Kaplan, MS, PhD

Published in: The Journal of Behavioral Health Services & Research | Issue 1/2024

Login to get access

Abstract

The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic’s ability to expand and improve access, especially for socially marginalized patients with OUD. New payment models, however, should reflect the high variation in cost for using a clinic’s clinical and voluntary psychosocial and recovery support services. The authors applied time-driven activity-based costing, a patient-level, micro-costing approach, to estimate the cost at an outpatient clinic that delivers medication for opiate used disorder (MOUD) and voluntary psychosocial and recovery support services. Much of the cost variation could be explained by classifying patients into three archetypes: (1) light touch (1–3 visits): no significant co-occurring psychiatric illness, stable housing, and easy to connect for ongoing OUD treatment in a traditional outpatient setting; (2) standard (average of 8 visits): initially requires an integrated team-based care model but soon stabilizes for transition to community-based outpatient care; (3) quad morbidity (> 20 visits): multiple co-occurring substance use disorders, unhoused, co-occurring medical and psychiatric complexity, and limited social supports. With the cost of the initial visit set at an indexed value of 100, an average light touch patient had a cost of 352, a standard patient was 718, and a quad morbidity patient was 1701. The cost structure revealed by this analysis provides the foundation for alternative payment models that would enable new MOUD clinics, staffed with multi-disciplinary care teams, and located for convenient access by high-risk patients, to be established and sustained.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
A Cost Model for a Low-Threshold Clinic Treating Opioid Use Disorder
Authors
Sarah E. Wakeman, MD
Elizabeth Powell, MPH
Syed Shehab, MD
Grace Herman, MS
Laura Kehoe, MD, MPH
Robert S. Kaplan, MS, PhD
Publication date
29-08-2023
Publisher
Springer US
Keywords
Opioids
Opioids
Published in
The Journal of Behavioral Health Services & Research / Issue 1/2024
Print ISSN: 1094-3412
Electronic ISSN: 1556-3308
DOI
https://doi.org/10.1007/s11414-023-09853-4

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Register your interest